Chemical Name: | 7-[3-(dimethylamino)propoxy]-6-methoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-(1-methylpiperidin-4-yl)quinazolin-4-amine |
CAS Number: | 1197196-48-7 |
Product Number: | AG008SSR(AGN-PC-073VDJ) |
Synonyms: | |
MDL No: | |
Molecular Formula: | C26H43N7O2 |
Molecular Weight: | 485.6653 |
UNC0224 is a potent and selective small molecule inhibitor that targets the protein lysine methyltransferase G9a. G9a is known to play a crucial role in the epigenetic regulation of gene expression through the methylation of histone H3 at lysine 9. By inhibiting G9a, UNC0224 effectively modulates gene expression patterns associated with various cellular processes.In chemical synthesis, UNC0224 serves as a valuable tool for researchers and scientists in the study of epigenetics and chromatin biology. Its ability to selectively inhibit G9a provides a means to investigate the specific role of this enzyme in gene regulation and chromatin structure. This opens up new possibilities for understanding the underlying mechanisms of diseases such as cancer and neurological disorders, where epigenetic dysregulation is implicated.Furthermore, UNC0224 can be utilized in the development of novel therapeutic strategies targeting G9a for potential medical applications. Its specificity and potency make it a promising candidate for drug discovery efforts aimed at modulating epigenetic pathways for the treatment of various diseases. Overall, UNC0224 represents a powerful tool for advancing our understanding of epigenetic mechanisms and exploring their therapeutic potential.